Abbott Laboratories (ABT)
Fixed asset turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 41,950,000 | 40,109,000 | 43,653,000 | 43,075,000 | 34,608,000 |
| Property, plant and equipment | US$ in thousands | — | — | 9,162,000 | 8,959,000 | 9,029,000 |
| Fixed asset turnover | — | — | 4.76 | 4.81 | 3.83 |
December 31, 2024 calculation
Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $41,950,000K ÷ $—K
= —
The fixed asset turnover ratio for Abbott Laboratories has shown a positive trend over the past few years, increasing from 3.83 in December 31, 2020, to 4.81 in December 31, 2021, and then marginally decreasing to 4.76 in December 31, 2022. This indicates that the company is generating more revenue relative to its investment in fixed assets, which is a positive sign of operational efficiency. However, the ratio is not available for the years 2023 and 2024, which may be due to missing or unavailable data.
Overall, Abbott Laboratories has been effectively utilizing its fixed assets to generate sales revenue, showcasing efficient asset management and potentially driving profitability. Monitoring this ratio over time can provide insights into the company's operational performance and management of assets.
Peer comparison
Dec 31, 2024